RHOKIINSA

This brand name is authorized in Austria, Estonia, Croatia, Ireland, Italy, Lithuania, Poland

Active ingredients

The drug RHOKIINSA contains one active pharmaceutical ingredient (API):

1 Netarsudil UNII VL756B1K0U - NETARSUDIL MESYLATE

Netarsudil, a Rho kinase inhibitor, is believed to reduce intraocular pressure (IOP) by increasing outflow of aqueous humor. Studies in animal and man suggest that the main mechanism of action is increased trabecular outflow. These studies also suggest that netarsudil lowers IOP by reducing episcleral venous pressure. Read about Netarsudil

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RHOKIINSA Eye drops, solution	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01EX05		S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EX Other antiglaucoma preparations
Discover more medicines within S01EX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1807152
Country: IT	Agenzia del Farmaco	Identifier(s): 048362014
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1088971
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100429757